PHARMACEUTICALS, INC. – Trademark Portfolio

Entity Type: 03

PHARMACEUTICALS, INC. holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 10 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include GERITOL and SOMINEX. The owner is based in NEWARK, NJ.

290 JELLIFF AVENUE

NEWARK, NJ

10 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

SOMINEX
SOMINEX
Registered 1955
NIRON
NIRON
Cancelled 1955
ZARUMIN
ZARUMIN
Cancelled 1954
ZARUTEX
ZARUTEX
Cancelled 1954
GERITOL
GERITOL
Registered 1954
TABULET
TABULET
Cancelled 1952
VIRAGEX
VIRAGEX
Cancelled 1952
SEDAGEL
SEDAGEL
Cancelled 1949

Trademark Classifications

PHARMACEUTICALS, INC.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (10 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does PHARMACEUTICALS, INC. have?

PHARMACEUTICALS, INC. has 10 U.S. trademarks filed with the USPTO. Of these, 2 registered, 8 cancelled.

What trademark classes does PHARMACEUTICALS, INC. file in?

PHARMACEUTICALS, INC. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are PHARMACEUTICALS, INC.'s most well-known trademarks?

PHARMACEUTICALS, INC.'s registered trademark portfolio includes well-known marks such as GERITOL and SOMINEX. These are among 2 currently registered trademarks in the portfolio.

What is PHARMACEUTICALS, INC.'s trademark registration success rate?

PHARMACEUTICALS, INC. has a 20% trademark registration rate, with 2 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.